Tag: CVS Health Corp

Healthy Returns: Stopping GLP-1s raises risk of heart attack, stroke and death, study says

Eli Lilly launches program to help boost employer coverage of obesity drugs in U.S.

Why Novo Nordisk’s Ireland expansion is key to fighting off Eli Lilly

Novo Nordisk to slash GLP-1 list prices by up to 50% in U.S. to cut costs for insured patients

Eli Lilly launches new form of obesity drug Zepbound with a month’s worth of doses in one pen

FDA chief Marty Makary says ‘everything should be over-the-counter’ unless drug is unsafe or addictive

The AI trade has entered a puzzling phase. Do we know who the winners are anymore?

CVS tops quarterly estimates, reaffirms profit outlook as turnaround plan takes effect

Novo Nordisk sues Hims & Hers over cheaper copycat versions of Wegovy pill, injections

Here are the retailers with the most store openings and closures planned for 2026